CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q1 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,935,394 | +22.7% | 99,640 | +35.9% | 0.00% | +33.3% |
| Q2 2023 | $2,392,449 | -8.1% | 73,343 | -0.8% | 0.00% | 0.0% |
| Q1 2023 | $2,602,054 | +11.0% | 73,943 | +44.6% | 0.00% | 0.0% |
| Q4 2022 | $2,343,372 | +24.3% | 51,143 | +32.7% | 0.00% | +50.0% |
| Q3 2022 | $1,886,000 | +60.4% | 38,543 | +28.7% | 0.00% | +100.0% |
| Q2 2022 | $1,176,000 | +4.7% | 29,943 | -1.8% | 0.00% | 0.0% |
| Q1 2022 | $1,123,000 | +193.2% | 30,500 | +263.1% | 0.00% | – |
| Q4 2021 | $383,000 | -50.5% | 8,400 | -76.5% | 0.00% | -100.0% |
| Q3 2020 | $773,000 | +418.8% | 35,700 | +95.1% | 0.00% | – |
| Q4 2017 | $149,000 | -43.8% | 18,300 | 0.0% | 0.00% | – |
| Q3 2017 | $265,000 | +85.3% | 18,300 | -3.0% | 0.00% | – |
| Q3 2013 | $143,000 | – | 18,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
| RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
| BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
| DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
| Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
| WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
| Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
| Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |